Pneumocystis carinii pneumonia is the most common and infection [3] . A variety of cell-mediated functions, including the production of cytokines and different T cell subsets, have often fatal opportunistic infection in patients infected with human immunodeficiency virus type 1 (HIV-1) [1] . It is estimated been implicated in this protective role [3] . that 80% of patients with AIDS not receiving anti-P. carinii Investigation into the host cellular immune response to P. prophylaxis ultimately develop P. carinii pneumonia during carinii has focused on the major surface glycoprotein (MSG), the course of their disease and, even in patients receiving prowhich is thought to play a crucial role in host-pathogen interacphylaxis, recurrent episodes of P. carinii pneumonia are relations. MSG is readily identified on the surface of all life-cycle tively common [2] . Cell-mediated immunity is believed to be stages of P. carinii [4] and appears to play a role in hostthe major mechanism by which the host controls P. carinii parasite interaction by mediating attachment of the organism to alveolar cells [5] . MSG is highly immunogenic and elicits both humoral and cellular immune responses [3, 4] . The immune response to infectious agents is often characterized by a dominance of either cell-mediated or humoral type effector mine, 100 U/mL penicillin, 100 mg/mL streptomycin, and 10% that HIV-infected asymptomatic subjects initially had a good heat-inactivated fetal calf serum [RPMI complete]), were plated T cell response to HIV peptides [7] . However, in the later in triplicate in flat-bottom 96-well plates. Cells were cultured at stages of disease, T cell proliferation in response to recall 37ЊC with 5% CO 2 for 5 days in medium alone or medium suppleantigens is impaired [8] 
Results
trol and Prevention criteria [10] , on the basis of CD4 lymphocyte counts, there were 14 patients with CD4 cell counts ú500/mL, 13
Our earlier studies have shown a blastogenic response to with 200-500/mL, and 26 with õ200/mL. Patients who had a whole P. carinii organisms by human PBMC from HIV-in-CD4 cell count of õ200/mL or a previous episode of P. carinii fected patients [11] . These experiments specifically investipneumonia received chemoprophylaxis, usually trimethoprim-sulgated the proliferative response to MSG by PBMC isolated famethoxazole. The CD4 cell counts were obtained on the same from healthy donors and from HIV-infected persons at all day that patients' blood was obtained for use in this study. stages of disease. Table 1 shows that there was a significant Antigen preparation. Due to the limited supply of humanderived P. carinii available for laboratory studies, organisms isodecrease in the proliferative response of PBMC from AIDS lated from rats are commonly being used in its place. P. carinii patients with õ200 CD4 cells/mL to MSG compared with were isolated from the lungs of corticosteroid-treated Lewis rats the response of PBMC from healthy controls. There was no as previously described [3] . To control for possible contaminating significant difference observed in the blastogenic response belung tissue remaining in the P. carinii preparation (lung control), tween patients with ú500 CD4 cells/mL or 200-500/mL and Lewis rats, housed in a protected environment to prevent exposure healthy controls. These data suggest that proliferative response to P. carinii, were also treated with corticosteroids. Lungs from by PBMC to MSG is dependent on the amount of circulating these rats were processed in the exact manner as described for P. , there was no as previously described [3] . MSG migrated as a band with a molecsignificant proliferative response by any of the groups to the ular mass of 120 kDa on SDS-PAGE gels under reducing condilung control (data not shown).
tions. The purity of the preparation was shown by Coomassie blue
We next examined whether MSG induced IFN-g secretion staining, reactivity with MSG-specific monoclonal antibodies, and from PBMC isolated from HIV-infected subjects. Table 1 by the absence of endotoxin as confirmed by the limulus amebocyte shows that there was a significant decrease in the amount of assay (õ0.125 U/mL; Whittaker Bioproducts, Walkersville, MD).
IFN-g secreted in response to MSG stimulation by PBMC
The protein concentration of the lung control was determined and isolated from patients with õ200 CD4 cells/mL. There was no adjusted to the same level as for MSG. difference between healthy controls and individuals with ú500 significant IFN-g secretion was observed following incubation previous episodes of P. carinii pneumonia was not due to increased numbers of CD4 cells; in fact, these patients had with lung control (data not shown).
We then investigated whether there was a difference in the significantly lower CD4 cell counts than did those who had not had previous P. carinii pneumonia (60 { 43 vs. 121 { levels of IL-4 secreted by PBMC in response to MSG and whether this was observed as HIV disease progressed. Table 62/mL; P õ .05). Table 2 also demonstrates the differences in cytokine secre-1 shows that there was no significant difference between any of the groups in the amount of IL-4 secreted. Of interest, in tion in response to MSG within the CDC class C 3 patients between those individuals who had a history of P. carinii pneucomparison with healthy controls, all of the patients with HIV infection had elevated levels of IL-4 following stimulation with monia and those who did not. Those with previous P. carinii pneumonia secreted significantly elevated levels of IL-4 in MSG; those with õ200 CD4 cells/mL demonstrated the highest levels of IL-4. No IL-4 was detected following incubation with response to MSG than those without previous P. carinii pneumonia. In contrast, there was no significant difference in the the lung control (data not shown).
In these experiments, we examined whether there were diflevel of IFN-g secreted in response to MSG from CDC class C 3 patients regardless of whether or not they had previously ferences in the proliferative response to MSG by PBMC from CDC class C 3 patients (õ200 CD4 cells/mL, AIDS-defining had P. carinii pneumonia. These data suggest that in the CDC class C 3 patients who had P. carinii pneumonia, there was a illness) who had had an episode of documented P. carinii pneumonia versus those who had not. As shown in table 2, predominately humoral immune response to MSG. those patients who had had previous P. carinii pneumonia (n Å 6) had significantly increased blastogenic responses to MSG compared with patients who had not had such an episode (n Discussion Å 8). The increased proliferative response of patients who had
The results presented here have shown that there was a significant reduction in the proliferative response to MSG by HIV-infected patients who had õ200 CD4 cells/mL. These response. Cayota et al. [8] reported similar results in prolifera-* P õ .01; value is significantly greater for comparisons within class C 3 patients.
tive experiments using isolated CD4 cell subsets from sympDownloaded from https://academic.oup.com/jid/article-abstract/177/1/238/855254 by guest on 09 December 2018 tomatic AIDS patients. Naive cells were found to display a to be seen whether the Th2 cell response observed following restimulation with MSG is helpful or harmful to the host. Howdefect in proliferative capacity while memory cells had a normal proliferative response. A recent report by Waldrop et al. ever, it is possible that correction of the Th1/Th2 balance may provide a basis for therapeutic intervention in HIV-infected indi- [12] demonstrated that CD4 cells from HIV-infected patients that were responsive to cytomegalovirus were dramatically inviduals when they are challenged by P. carinii. creased in Ç40% of the patients compared with control subjects, including those with relatively advanced disease. Thus,
